{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:22:12Z","timestamp":1794057732196,"version":"4.8.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21nf0101636h0001"],"award-info":[{"award-number":["21nf0101636h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ophtha.2022.10.017","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T20:52:06Z","timestamp":1666731126000},"page":"256-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Ocular Adverse Events after Coronavirus Disease 2019 mRNA Vaccination"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7944-6923","authenticated-orcid":false,"given":"Yohei","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Yamana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Iwagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-2578","authenticated-orcid":false,"given":"Sachiko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9821-0513","authenticated-orcid":false,"given":"Yoshinori","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Michihata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikatsu","family":"Kaburaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2022.10.017_bib1","author":"World Health Organization"},{"key":"10.1016\/j.ophtha.2022.10.017_bib2","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41591-022-01832-0","article-title":"Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years","volume":"28","author":"Arbel","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ophtha.2022.10.017_bib3","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2022.10.017_bib4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2022.10.017_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068665","article-title":"SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study","author":"Husby","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2022.10.017_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijid.2021.09.075","article-title":"Bilateral uveitis after inoculation with COVID-19 vaccine: a case report","volume":"113","author":"Pan","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ophtha.2022.10.017_bib7","first-page":"1","article-title":"Nonarteritic anterior ischemic optic neuropathy following COVID-19 vaccination: consequence or coincidence","volume":"2021","author":"Tsukii","year":"2021","journal-title":"Case Rep Ophthalmol Med"},{"key":"10.1016\/j.ophtha.2022.10.017_bib8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/09273948.2021.1949478","article-title":"Panuveitis following vaccination for COVID-19","volume":"29","author":"Mudie","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2022.10.017_bib9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/jamaophthalmol.2021.3477","article-title":"Association of ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi","volume":"139","author":"Pichi","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.10.017_bib10","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1080\/09273948.2022.2079534","article-title":"COVID-19 adenoviralvector vaccine and central retinal vein occlusion","volume":"30","author":"Romano","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2022.10.017_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10633-022-09880-0","article-title":"Unilateral optic neuritis after vaccination against the coronavirus disease: two case reports","volume":"145","author":"Wang","year":"2022","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.10.017_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/19418744221090426","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease and transverse myelitis probably associated with SARS-CoV-2 mRNA vaccines: two case reports","volume":"12","author":"Morena","year":"2022","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.ophtha.2022.10.017_bib13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ophtha.2022.05.015","article-title":"Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and non-infectious uveitis: a population-based study","volume":"129","author":"Tomkins-Netzer","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2022.10.017_bib14","series-title":"Self-Controlled Case Series Studies: A Modelling Guide with R","author":"Farrington","year":"2018"},{"key":"10.1016\/j.ophtha.2022.10.017_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.37737\/ace.3.3_67","article-title":"Introduction to self-controlled study design","volume":"3","author":"Iwagami","year":"2021","journal-title":"Ann Clin Epidemiol"},{"key":"10.1016\/j.ophtha.2022.10.017_bib16","doi-asserted-by":"crossref","first-page":"m2930","DOI":"10.1136\/bmj.m2930","article-title":"Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis","author":"Hviid","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2022.10.017_bib17","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: the self-controlled case series method","volume":"25","author":"Whitaker","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.ophtha.2022.10.017_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069590","article-title":"Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study","volume":"377","author":"Katsoularis","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2022.10.017_bib20","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1080\/09273948.2022.2044058","article-title":"Recurrent anterior non-necrotizing scleritis as an adverse event of ChAdOx1 nCoV-19 (Vaxzevria) vaccine","volume":"30","author":"Hernanz","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2022.10.017_bib21","first-page":"1","article-title":"Peripheral ulcerative keratitis secondary to the inactive COVID-19 vaccine-CoronaVac","author":"Penbe","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2022.10.017_bib22","first-page":"1","article-title":"Posterior scleritis following COVID-19 vaccination: a case report","author":"Younus","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2022.10.017_bib23","article-title":"Ischemic retinal events after COVID-19 vaccination","volume":"26","author":"Priluck","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ophtha.2022.10.017_bib24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4103\/ijo.IJO_1757_21","article-title":"Central retinal vein occlusion post-COVID-19 vaccination","volume":"70","author":"Sonawane","year":"2022","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2022.10.017_bib25","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.oret.2022.03.012","article-title":"Association between retinal vein occlusion and life\u2019s simple 7 cardiovascular health metrics: a large claims database study","volume":"6","author":"Hashimoto","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2022.10.017_bib26","article-title":"Association between retinal vein occlusion and early-stage hypertension: a propensity score analysis using a large claims database","author":"Hashimoto","year":"2022","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2022.10.017_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103739","article-title":"COVID-19 vaccine associated demyelination & its association with MOG antibody","volume":"60","author":"Netravathi","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.ophtha.2022.10.017_bib28","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1177\/13524585221109397","article-title":"A\u00a0disproportionality analysis for the association of central nervous system demyelinating diseases with COVID-19 vaccination using the World Health Organization pharmacovigilance database","volume":"28","author":"Kim","year":"2022","journal-title":"Mult Scler"},{"key":"10.1016\/j.ophtha.2022.10.017_bib29","author":"Qiu"},{"key":"10.1016\/j.ophtha.2022.10.017_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jclinepi.2021.08.028","article-title":"Causal analyses of existing databases: no power calculations required","volume":"144","author":"Hern\u00e1n","year":"2022","journal-title":"J\u00a0Clin Epidemiol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642022008326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642022008326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:06:23Z","timestamp":1773237983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642022008326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0161642022008326"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2022.10.017","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Adverse Events after Coronavirus Disease 2019 mRNA Vaccination","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2022.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}